Advertisement

Pre- and In-Hospital Antiarrhythmic Prevention of Ventricular Fibrillation Complicating Acute Myocardial Infarction

  • K. I. Lie
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 167)

Abstract

Ventricular fibrillation complicating acute myocardial infarction especially occur during the first hours of infarction in the pre-hospital setting and contributes to the major cause of out-of-hospital mortality in coronary heart disease [1–3]. Various attempts have been made in the last years to evaluate the efficacy of antiarrhythmic prevention in patients with suspected acute myocardial infarction seen outside the hospital [4–7].

Keywords

Acute Myocardial Infarction Ventricular Fibrillation Antiarrhythmic Drug Ventricular Ectopic Beat Suspected Acute Myocardial Infarction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pantridge JF, Geddes JS (1967) A mobile intensive care unit on the management of myocardial infarction. Lancet II:271-273CrossRefGoogle Scholar
  2. 2.
    Lawrie DM, Higgins MR, Oliver MF, Julian DG, Donald KW (1968) Ventricular fibrillation complicating acute myocardial infarction. Lancet II:523CrossRefGoogle Scholar
  3. 3.
    Adgey AA, Pantridge JF (1971) Acute phase of myocardial infarction. Lancet II:501CrossRefGoogle Scholar
  4. 4.
    Valentine PA, Frew JL, Mashhord ML (1974) Lidocaine in the prevention of Sudden Death in the prehospital phase of acute infarction. N Engl J Med 291:1327–1331PubMedCrossRefGoogle Scholar
  5. 5.
    Lie KI, Liem KL, Louridtz WJ, Janse MJ, Willebrands AF, Durrer D (1978) Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 h after a 300 mg intramuscular injection. Am J Cardiol 42:486–488PubMedCrossRefGoogle Scholar
  6. 6.
    Wennerblom B, Holmberg S, Ryden L, Wedel H (1982) Antiarrhythmic efficacy and side-effects of lidocaine given in the pre-hospital phase of acute myocardial infarction. Eur Heart J 3:516–524PubMedGoogle Scholar
  7. 7.
    Koster RW, Dunning AJ (1983) Life-threatening arrhythmias in the pre-hospital phase of acute myocardial infarction. In: Manger Cats V (ed) Arrhythmias in myocardial ischemia. Proceedings of symposium Academic Medical Center, Amsterdam 22 April, 1983, pp 51–58Google Scholar
  8. 8.
    Arnsdorf MF (1976) Electrophysiologic properties of antridysrhythmic drugs as a rational basis for therapy. Med Clin North Am 60:213–232PubMedGoogle Scholar
  9. 9.
    Lown B, Fakhro AM, Hood WB, Thorn GW (1967) The coronary care unit. New perspectives and directions. JAMA 199:156–160Google Scholar
  10. 10.
    Lie KL, Wellens HJJ, Liem KL, Durrer D (1977) Treatment and prevention of primary ventricular fibrillation complicating acute myocardial infarction. Acta Cardiologica, suppl XXII: 107–115Google Scholar
  11. 11.
    Logan KR, Mcllwaine WJ, Adgey AAJ, Pantridge JF (1981) Recurrence of ventricular fibrillation in acute ischemic heart disease. Circulation 64:1163–1168PubMedCrossRefGoogle Scholar
  12. 12.
    Horwitz RI, Feinstein AR (1980) New method to evaluate therapeutic efficacy, with evidence that lidocaine prophylaxis improves survical for patients with myocardial infarction. Clin Res 18:474AGoogle Scholar
  13. 13.
    Lie KI, Wellens HJJ, Downar E, Durrer D (1975) Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 52:755–759PubMedGoogle Scholar
  14. 14.
    Dhurandhar RW, MacMillan RL, Brown KWG (1971) Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol 27 :347–351PubMedCrossRefGoogle Scholar
  15. 15.
    Campbell RW (1980) Relation of ventricular arrhythmias to primary ventricular fibrillation. Br Heart J 43:100Google Scholar
  16. 16.
    Lie KL, Wellens HJJ, van Capelle FJL, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation. N Engl J Med 291:1324–1326PubMedCrossRefGoogle Scholar
  17. 17.
    DaSilva RA, Lown B, Hennekens CH, Casscells W (1981) Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomized trials. Lancet II:855–858CrossRefGoogle Scholar
  18. 18.
    Campbell RWF (1981) Placebo-controlled study of prophylaxis of ventricular arrhythmias. In: Harrison DC, Hall GK (eds) Cardiac Arrhythmias. Medical Publishers ,Boston ,Massachusetts ,pp 195–204Google Scholar
  19. 19.
    Lie ,KI ,Liem KL ,Durrer ,D (1978) Value and limitations of lignocaine in the prevention of primary ventricular fibrillation complicating acute myocardial infarction. In: Hjalmarson A ,Wilhelmsen L (ed) Acute and long-term medical management of myocardial infarction. A Lindgren & Söner AB ,Mölndal ,pp 166–169Google Scholar
  20. 20.
    Wyman MG, Hammersmith L (1974) Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Am J Cardiol 33:661–666PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • K. I. Lie

There are no affiliations available

Personalised recommendations